126 related articles for article (PubMed ID: 19281283)
1. Safety and performance of targeted renal therapy: the Be-RITe! Registry.
Weisz G; Filby SJ; Cohen MG; Allie DE; Weinstock BS; Kyriazis D; Walker CM; Moses JW; Danna P; Fearon WF; Sachdev N; Wiechmann BN; Vora K; Findeiss L; Price MJ; Mehran R; Leon MB; Teirstein PS
J Endovasc Ther; 2009 Feb; 16(1):1-12. PubMed ID: 19281283
[TBL] [Abstract][Full Text] [Related]
2. Targeted renal therapy: a potential weapon in the battle against CIN.
Boyle JR
J Endovasc Ther; 2009 Feb; 16(1):13-4. PubMed ID: 19281284
[No Abstract] [Full Text] [Related]
3. Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial.
Allie DE; Lirtzman MD; Wyatt CH; Keller VA; Mitran EV; Hebert CJ; Patlola R; Veerina KK; Walker CM
J Endovasc Ther; 2007 Aug; 14(4):520-7. PubMed ID: 17696627
[TBL] [Abstract][Full Text] [Related]
4. Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
Talati S; Kirtane AJ; Hassanin A; Mehran R; Leon MB; Moses JW; Weisz G
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):506-9. PubMed ID: 22469256
[TBL] [Abstract][Full Text] [Related]
5. Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Ng MK; Tremmel J; Fitzgerald PJ; Fearon WF
J Interv Cardiol; 2006 Feb; 19(1):75-9. PubMed ID: 16483344
[TBL] [Abstract][Full Text] [Related]
6. Contrast-induced nephropathy: protective role of fenoldopam.
Caixeta A; Dogan O; Weisz G
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):497-505. PubMed ID: 22642656
[TBL] [Abstract][Full Text] [Related]
7. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.
Merten GJ; Burgess WP; Gray LV; Holleman JH; Roush TS; Kowalchuk GJ; Bersin RM; Van Moore A; Simonton CA; Rittase RA; Norton HJ; Kennedy TP
JAMA; 2004 May; 291(19):2328-34. PubMed ID: 15150204
[TBL] [Abstract][Full Text] [Related]
8. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
9. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.
Adolph E; Holdt-Lehmann B; Chatterjee T; Paschka S; Prott A; Schneider H; Koerber T; Ince H; Steiner M; Schuff-Werner P; Nienaber CA
Coron Artery Dis; 2008 Sep; 19(6):413-9. PubMed ID: 18955835
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
11. Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures.
Ueda H; Yamada T; Masuda M; Okuyama Y; Morita T; Furukawa Y; Koji T; Iwasaki Y; Okada T; Kawasaki M; Kuramoto Y; Naito T; Fujimoto T; Komuro I; Fukunami M
Am J Cardiol; 2011 Apr; 107(8):1163-7. PubMed ID: 21349483
[TBL] [Abstract][Full Text] [Related]
12. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
[TBL] [Abstract][Full Text] [Related]
13. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
Teirstein PS; Price MJ; Mathur VS; Madyoon H; Sawhney N; Baim DS
Am J Cardiol; 2006 Apr; 97(7):1076-81. PubMed ID: 16563920
[TBL] [Abstract][Full Text] [Related]
14. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
15. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
16. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry.
Fujihara M; Kawasaki D; Shintani Y; Fukunaga M; Nakama T; Koshida R; Higashimori A; Yokoi Y;
Catheter Cardiovasc Interv; 2015 Apr; 85(5):870-7. PubMed ID: 25380326
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
18. Sodium bicarbonate for the prevention of contrast-induced nephropathy: the efficacy of high concentration solution.
Tamai N; Ito S; Nakasuka K; Morimoto K; Miyata K; Inomata M; Yoshida T; Suzuki S; Murakami Y; Sato K
J Invasive Cardiol; 2012 Sep; 24(9):439-42. PubMed ID: 22954563
[TBL] [Abstract][Full Text] [Related]
19. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
[TBL] [Abstract][Full Text] [Related]
20. The High Risk of Contrast-induced Nephropathy in Patients with Suspected Pulmonary Embolism Despite Three Different Prophylaxis: A Randomized Controlled Trial.
Turedi S; Erdem E; Karaca Y; Tatli O; Sahin A; Turkmen S; Gunduz A
Acad Emerg Med; 2016 Oct; 23(10):1136-1145. PubMed ID: 27411777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
